Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05618652 · ClinicalTrials.gov registry record · NA

Pilot Testing of an Equity Focused and Trauma-informed Communication Intervention During Family-centered Rounds

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
51
Enrollment target

NCT05618652: Completed NA study, sponsored by Duke University.

NCT05618652 is a NA study that has completed, run by Duke University. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05618652, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target

Study Summary

Development and pilot testing of a clinician coaching communication intervention to improve communication between medical teams and caregivers (parents, family members) of children in the hospital. Our team is specifically focused on improving partnership, respect, and collaboration with Black and Latinx caregivers of children in the hospital by incorporating elements from trauma-informed care and racial equity into a communication intervention. The investigators will explore the impact of this intervention on communication quality, caregiver trust, caregiver satisfaction, and hospital readmissions.

Interventions

  • BEHAVIORAL Equity Focused and Trauma-Informed Communication Intervention

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2024-02-01
Est. Completion 2025-03-29
Phase NA
Duke University

1,725 total trials

What the finished NCT05618652 record still lists

NCT05618652 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Equity Focused and Trauma-Informed Communication Intervention is the first listed.

NCT05618652 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05618652 about?

NCT05618652 is a clinical study titled "Pilot Testing of an Equity Focused and Trauma-informed Communication Intervention During Family-centered Rounds". Development and pilot testing of a clinician coaching communication intervention to improve communication between medical teams and caregivers (parents, family members) of children in the hospital. Our team is specifically focused on improving partnership, respect, and collaboration with Black and L...

What is the current status of trial NCT05618652?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2024-02-01. Estimated completion is 2025-03-29.

What interventions are being tested in trial NCT05618652?

The interventions under investigation include: Equity Focused and Trauma-Informed Communication Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05618652?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05618652's enrollment target sits among peer trials

51 1279th of 2000 higher than 722 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02701153 · 51 participants · NA

    Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • NCT03663790 · 51 participants · NA

    Effects of Gait Retraining on Lower Extremity Biomechanics

  • NCT03874052 · 51 participants · Phase 1

    Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

  • NCT04704661 · 51 participants · Phase 1

    Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05618652, the US trial registry maintained by the National Library of Medicine. NCT05618652 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.